Health
Body’s immune response drives production of non-functional COVID ‘gateway protein’: Study – Times of India
In the study, scientists, including those from the Francis Crick Institute in London, analysed existing genetic dat
Some immune system molecules trigger the production of a non-functional variant of the human protein used by the novel coronavirus to enter and infect host cells, according to a study that sheds light on the body’s natural defence against COVID-19. The research, published in the journal Nature Genetics, examined the genetic information that codes for the ACE2 receptor, to which the SARS-CoV-2 virus must bind in order to enter and infect human cells.
In the study, scientists, including those from…
-
Noosa News7 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business12 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Noosa News10 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?